USD 0.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.55 Million USD | 28.75% |
2022 | 4.33 Million USD | -36.41% |
2021 | 6.8 Million USD | -8.15% |
2020 | 7.41 Million USD | 138.97% |
2019 | 3.1 Million USD | 3233.33% |
2018 | -99 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q2 | 2.72 Million USD | 22.02% |
2023 Q1 | 2.23 Million USD | 215.54% |
2023 Q3 | 1.94 Million USD | -28.76% |
2023 Q4 | -577 Thousand USD | -129.71% |
2023 FY | 5.57 Million USD | 28.75% |
2022 Q4 | 708 Thousand USD | -45.5% |
2022 Q3 | 1.29 Million USD | -47.64% |
2022 FY | 4.33 Million USD | -36.41% |
2022 Q2 | 2.48 Million USD | 21.74% |
2022 Q1 | 2.03 Million USD | 800.34% |
2021 FY | 6.8 Million USD | -8.15% |
2021 Q4 | -291 Thousand USD | -111.48% |
2021 Q3 | 2.53 Million USD | 8.61% |
2021 Q2 | 2.33 Million USD | 4.62% |
2021 Q1 | 2.23 Million USD | -1.8% |
2020 Q4 | 2.27 Million USD | 9.6% |
2020 Q3 | 2.07 Million USD | 128.56% |
2020 Q2 | 907 Thousand USD | -58.03% |
2020 Q1 | 2.16 Million USD | 44.94% |
2020 FY | 7.41 Million USD | 138.97% |
2019 Q1 | - USD | 0.0% |
2019 FY | 3.1 Million USD | 3233.33% |
2019 Q3 | 957 Thousand USD | 46.33% |
2019 Q4 | 1.49 Million USD | 55.8% |
2019 Q2 | 654 Thousand USD | 0.0% |
2018 FY | -99 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Bright Green Corporation | -237.01 Thousand USD | 2866.058% |
BioQuest Corp. | - USD | -Infinity% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 97.043% |
Guardion Health Sciences, Inc. | 5.39 Million USD | -21.531% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | -56.39 Thousand USD | 11725.556% |
Instadose Pharma Corp. | - USD | -Infinity% |